NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,096 filers reported holding NOVARTIS A G in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,794,529 | +0.9% | 27,435 | 0.0% | 0.00% | +33.3% |
| Q2 2023 | $2,768,466 | +206.0% | 27,435 | +179.0% | 0.00% | +200.0% |
| Q1 2023 | $904,820 | -40.8% | 9,835 | -41.6% | 0.00% | -50.0% |
| Q4 2022 | $1,529,085 | +19.4% | 16,855 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,281,148 | -97.6% | 16,855 | -97.3% | 0.00% | -98.3% |
| Q3 2020 | $54,267,000 | -2.7% | 624,044 | -2.3% | 0.12% | -7.7% |
| Q2 2020 | $55,768,000 | -9.5% | 638,511 | -14.5% | 0.13% | -21.7% |
| Q1 2020 | $61,602,000 | -28.3% | 747,149 | -17.6% | 0.17% | -6.2% |
| Q4 2019 | $85,866,000 | +7.7% | 906,807 | -1.1% | 0.18% | +1.7% |
| Q3 2019 | $79,714,000 | +9.4% | 917,320 | +14.9% | 0.17% | +11.5% |
| Q2 2019 | $72,895,000 | +6.8% | 798,331 | +12.5% | 0.16% | +2.0% |
| Q1 2019 | $68,242,000 | – | 709,813 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |